Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

J&J Tries to Expand Invokana Label to Include Cardiovascular Benefits

October 9, 2017 By Law Offices of Thomas J. Lamb, P.A.

Johnson & Johnson's, the drug manufacturer of diabetes drugs Invokana, Invokamet, and Invokamet XR, recently submitted a supplemental new drug application (sNDA) to the FDA to request expansion of the labels for these drugs. If granted, the new label would include a cardiovascular indication concerning the reduction of risk of cardiovascular … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Cardiovascular death, diabetes drugs amputation, diabetes drugs side effects, drug label changes, FDA, foot amputations, Heart Attacks, Invokamet, invokamet xr, Invokana, johnson & johnson's, leg amputations, nonfatal myocardial infarctions, sNDA, supplemental new drug application, toe amputations, type 2 diabetes drugs

“Dear Doctor” Letter About Invokana And Amputations Was Sent In Canada

September 12, 2017 By Law Offices of Thomas J. Lamb, P.A.

In September 2017 Health Canada required Janssen, the drug company responsible for Invokana and Invokamet, to send a Dear Healthcare Professional Letter — commonly referred to as a “Dear Doctor” letter — about the lower limb amputations side effect. Here are some of the points presented in this September 2017 Janssen letter to Canadian … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Amputations, foot amputations, Invokamet, Invokana, leg amputations, lower limb amputations, toe amputations

FDA Reports Show Extent And Nature of Invokana-Amputation Side Effect

August 15, 2017 By Law Offices of Thomas J. Lamb, P.A.

A British medical journal, The Lancet Diabetes & Endocrinology, published this Correspondence item on July 18, 2017, “SGTL2 inhibitors and amputations in the US FDA Adverse Event Reporting System”. The main point of that article is set forth in this excerpt: In summary, this pharmacovigilance analysis confirms that use of canagliflozin, but … [Read more...]

Filed Under: Unsafe Drugs Tagged With: amputation risks, foot amputations, Invokamet, Invokana, leg amputations, lower limb amputations, toe amputations

Invokana Gets “Black-Box Warning” For Risk Of Leg And Foot Amputations

August 1, 2017 By Law Offices of Thomas J. Lamb, P.A.

In the final week of July 2017, the FDA issued a notification that it had approved a revised drug label for Invokana and Invokamet, as well as a revised Medication Guide for these two diabetes drugs from Janssen Pharmaceuticals. From the most recent drug label, or Full Prescribing Information, for Invokana (accessed 7/27/17), here is the text of … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Amputations, FDA drug label warnings, foot amputations, Invokamet, Invokana, leg amputations, toe amputations

Risk of Lower Limb Amputations Doubled with Invokana and Invokamet Use

May 17, 2017 By Law Offices of Thomas J. Lamb, P.A.

As of yesterday, May 16, 2017, the FDA issued a Drug Safety Communication regarding an increased risk of leg and foot amputations due to use of popular diabetes drugs Invokana, Invokamet, and Invokamet XR, which contain canagliflozin. These drugs belong to the sodium glucose cotransporter 2 (SGLT2) inhibitor class, and are the subjects of … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Amputations, canagliflozin, dapagliflozin, drug injury, EMA, empagliflozin, Farxiga, FDA, foot amputations, Invokamet, Invokana, Jardiance, leg amputations, sglt2 inhibitors, side effects, toe amputations, Xigduo, xigduo xr

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.